BFEC
CLGN icon

Benjamin F. Edwards & Company’s CollPlant Biotechnologies CLGN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$197K Sell
39,760
-10,690
-21% -$59.3K ﹤0.01% 913
2024
Q1 		$272K Buy
50,450
+300
+0.6% +$1.62K ﹤0.01% 820
2023
Q4 		$320K Buy
50,150
+5,100
+11% +$27.9K 0.01% 733
2023
Q3 		$254K Sell
45,050
-4,160
-8% -$27.5K 0.01% 670
2023
Q2 		$399K Sell
49,210
-16,701
-25% -$122K 0.02% 567
2023
Q1 		$463K Buy
65,911
+4,861
+8% +$47.7K 0.02% 503
2022
Q4 		$510K Sell
61,050
-4,360
-7% -$29.8K 0.02% 462
2022
Q3 		$447K Sell
65,410
-6,400
-9% -$51.9K 0.02% 459
2022
Q2 		$585K Sell
71,810
-3,460
-5% -$31.8K 0.03% 419
2022
Q1 		$861K Buy
75,270
+16,576
+28% +$182K 0.04% 368
2021
Q4 		$960K Buy
58,694
+1,050
+2% +$18.7K 0.04% 351
2021
Q3 		$973K Sell
57,644
-6,990
-11% -$126K 0.05% 345
2021
Q2 		$1.37M Sell
64,634
-5,186
-7% -$82.9K 0.07% 282
2021
Q1 		$938K Buy
69,820
+55,300
+381% +$834K 0.05% 343
2020
Q4 		$156K Buy
+14,520
New +$117K 0.01% 702

Other funds holding CLGN

PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
RWMG
Redwood Wealth Management Group Medford, New Jersey $232M AUM 22.66% 1-Year Est. Return

Benjamin F. Edwards & Company's CLGN Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its CollPlant Biotechnologies (CLGN) stake by 21% in Q2 2024, selling an estimated $59.3K and leaving 39,760 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #913.

Benjamin F. Edwards & Company first reported a position in CLGN in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.37M in Q2 2021. 16 funds tracked by Wall St. Rank hold CLGN as of Q2 2024.

  • Benjamin F. Edwards & Company held 39,760 shares of CollPlant Biotechnologies worth $197K as of Q2 2024.
  • Benjamin F. Edwards & Company sold 10,690 CollPlant Biotechnologies shares in Q2 2024, an estimated $59.3K.
  • CollPlant Biotechnologies made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #913 holding.
  • Benjamin F. Edwards & Company first reported a position in CollPlant Biotechnologies in Q4 2020 and has held it in 15 quarters since.
  • Benjamin F. Edwards & Company's CollPlant Biotechnologies position peaked at $1.37M in Q2 2021.
  • 16 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.